• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

6-Bromopyrimidine-4-carboxylic acid (CAS 1555494-28-4): A Versatile Building Block in Medicinal Chemistry

6-Bromopyrimidine-4-carboxylic acid (CAS 1555494-28-4) is an important heterocyclic compound that has gained significant attention in pharmaceutical research and organic synthesis. As a brominated pyrimidine derivative, this compound serves as a crucial intermediate in the development of various biologically active molecules. The presence of both bromo substituent and carboxylic acid functional group makes it particularly valuable for further chemical modifications.

The molecular structure of 6-Bromopyrimidine-4-carboxylic acid features a pyrimidine ring system with a bromine atom at the 6-position and a carboxylic acid group at the 4-position. This specific substitution pattern allows for diverse chemical transformations, making it a versatile building block in drug discovery. Recent studies have highlighted its utility in the synthesis of kinase inhibitors, which are currently a hot topic in cancer research and targeted therapy development.

In the pharmaceutical industry, 6-Bromopyrimidine-4-carboxylic acid derivatives have shown promising results in the development of novel therapeutic agents. Researchers are particularly interested in its potential applications for protein kinase modulation, a rapidly growing field in precision medicine. The compound's ability to serve as a scaffold for various pharmacophores makes it valuable for structure-activity relationship (SAR) studies.

From a synthetic chemistry perspective, 6-Bromopyrimidine-4-carboxylic acid offers multiple reactive sites for further functionalization. The bromine atom can participate in various cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are frequently searched topics in organic chemistry forums. Meanwhile, the carboxylic acid group enables amide bond formation or esterification, expanding its utility in combinatorial chemistry approaches.

The growing demand for pyrimidine-based compounds in drug development has increased interest in 6-Bromopyrimidine-4-carboxylic acid as a key intermediate. Pharmaceutical companies and research institutions are actively investigating its potential in creating small molecule therapeutics for various diseases. This aligns with current trends in personalized medicine and the search for more selective drug candidates with fewer side effects.

Quality control and characterization of 6-Bromopyrimidine-4-carboxylic acid typically involve advanced analytical techniques. High-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry are commonly employed to ensure the compound's purity and structural integrity. These analytical methods are frequently discussed in scientific communities and represent common search queries among researchers working with heterocyclic compounds.

In material science applications, derivatives of 6-Bromopyrimidine-4-carboxylic acid have shown potential in the development of organic electronic materials. The π-conjugated system of the pyrimidine ring, combined with the modifiable functional groups, makes it interesting for designing organic semiconductors and photovoltaic materials. This application area has gained momentum with the increasing focus on sustainable energy solutions.

The synthesis and handling of 6-Bromopyrimidine-4-carboxylic acid require proper laboratory practices and equipment. While not classified as hazardous under normal conditions, standard precautions for handling organic compounds should be followed. Researchers often search for information about proper storage conditions, solubility characteristics, and compatibility with various reaction conditions when working with this compound.

Recent patent literature reveals growing intellectual property activity surrounding 6-Bromopyrimidine-4-carboxylic acid derivatives, particularly in the areas of anticancer agents and anti-inflammatory drugs. This reflects the compound's importance in current medicinal chemistry research and its potential for commercial applications. The increasing number of publications and patents mentioning this compound indicates its rising significance in pharmaceutical development.

From a market perspective, the demand for high-quality 6-Bromopyrimidine-4-carboxylic acid has been steadily increasing. Suppliers are focusing on providing the compound with various purity grades to meet different research and production needs. The compound's price and availability are common search queries among purchasing agents and researchers in the fine chemicals sector.

Future research directions for 6-Bromopyrimidine-4-carboxylic acid may include exploring its applications in bioconjugation chemistry and proteolysis targeting chimera (PROTAC) technology, both of which are emerging fields in drug discovery. The compound's structural features make it potentially valuable for these innovative approaches, which are currently receiving substantial attention in the scientific community.

In conclusion, 6-Bromopyrimidine-4-carboxylic acid (CAS 1555494-28-4) represents a valuable chemical building block with diverse applications in medicinal chemistry and material science. Its unique structural features and reactivity profile continue to make it a compound of interest for researchers working on cutting-edge therapeutic development and advanced materials design.

• 1805551-65-8((6-Bromopyrimidin-4-yl)methanol)
• 1807121-06-7(Ethyl 4-bromopyrimidine-6-carboxylate)
• 105802-36-6(4-Pyrimidinecarboxylic acid, hydrobromide (1:1))
• 880091-37-2(4-Pyrimidinecarboxylic acid, 2,6-dibromo-, methyl ester)
• 1209459-80-2(Methyl 6-bromopyrimidine-4-carboxylate)
• 1206249-60-6(2-amino-6-bromo-pyrimidine-4-carboxylic acid)
• 1211515-50-2(2-Bromopyrimidine-4-carboxylic acid)
• 1805550-15-5(6-Bromopyrimidine-4-carbaldehyde)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)